Alnylam Pharmaceuticals Inc (ALNY)
262.63
-1.84
(-0.70%)
USD |
NASDAQ |
Nov 14, 11:24
Alnylam Pharmaceuticals Total Return Level: 264.47 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 264.47 |
November 12, 2024 | 268.95 |
November 11, 2024 | 279.82 |
November 08, 2024 | 277.43 |
November 07, 2024 | 272.22 |
November 06, 2024 | 273.01 |
November 05, 2024 | 265.29 |
November 04, 2024 | 269.95 |
November 01, 2024 | 273.91 |
October 31, 2024 | 266.59 |
October 30, 2024 | 281.49 |
October 29, 2024 | 284.69 |
October 28, 2024 | 286.91 |
October 25, 2024 | 284.86 |
October 24, 2024 | 293.69 |
October 23, 2024 | 294.87 |
October 22, 2024 | 296.48 |
October 21, 2024 | 292.01 |
October 18, 2024 | 295.93 |
October 17, 2024 | 296.75 |
October 16, 2024 | 300.55 |
October 15, 2024 | 287.36 |
October 14, 2024 | 283.32 |
October 11, 2024 | 284.32 |
October 10, 2024 | 278.62 |
Date | Value |
---|---|
October 09, 2024 | 270.90 |
October 08, 2024 | 271.19 |
October 07, 2024 | 266.77 |
October 04, 2024 | 267.99 |
October 03, 2024 | 269.53 |
October 02, 2024 | 271.55 |
October 01, 2024 | 276.06 |
September 30, 2024 | 275.03 |
September 27, 2024 | 274.91 |
September 26, 2024 | 274.57 |
September 25, 2024 | 272.73 |
September 24, 2024 | 271.00 |
September 23, 2024 | 271.83 |
September 20, 2024 | 273.88 |
September 19, 2024 | 276.33 |
September 18, 2024 | 273.15 |
September 17, 2024 | 274.46 |
September 16, 2024 | 270.37 |
September 13, 2024 | 265.27 |
September 12, 2024 | 261.73 |
September 11, 2024 | 261.91 |
September 10, 2024 | 256.21 |
September 09, 2024 | 253.16 |
September 06, 2024 | 246.78 |
September 05, 2024 | 251.48 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
90.46
Minimum
Nov 14 2019
300.55
Maximum
Oct 16 2024
172.48
Average
165.07
Median
Jan 14 2021
Total Return Level Benchmarks
Pfizer Inc | 95.41 |
BridgeBio Pharma Inc | 24.79 |
Biomarin Pharmaceutical Inc | 66.66 |
Gilead Sciences Inc | 128.63 |
Regeneron Pharmaceuticals Inc | 804.33 |